Modeling Patient Response to a Therapeutic Diet in Crohn's Disease

NAUnknownINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

February 12, 2023

Study Completion Date

June 12, 2023

Conditions
Crohn Disease
Interventions
OTHER

Therapeutic diet Intervention

The CD-TDI will incorporate global principles of the Mediterranean Diet (MD) refined to inform specific food choices based on our pilot data results and published literature reported mechanisms of mitigating inflammation in IBD. Patient compliance will be measured in three ways: 1) Mediterranean diet score checklists completed every 3 weeks at the face-to-face visits; 2) goal attainment scores captured weekly to identify the goals set, and the goals attained 47; and 3) fatty acids profiled from red blood cells to identify if fat intake reflects CD-TDI fat recommendations: 35% total calories from fat, 15% from MUFA, 13% from SFA and 6% from PUFA with a 8 n6:n:3 ratio of 8:1

Trial Locations (1)

T2N 4Z6

TRW building, Foothills, University of Calgary, Calgary

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Crohn's and Colitis Foundation

OTHER

collaborator

University of Alberta

OTHER

collaborator

University of Guelph

OTHER

collaborator

University of British Columbia

OTHER

collaborator

Alphabiomics

UNKNOWN

collaborator

University of Birmingham

OTHER

lead

University of Calgary

OTHER

NCT04596566 - Modeling Patient Response to a Therapeutic Diet in Crohn's Disease | Biotech Hunter | Biotech Hunter